| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:07:46 -0700 |
| HMDB ID |
HMDB00026 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Ureidopropionic acid |
| Description |
Ureidopropionic acid is an intermediate in the metabolism of uracil. More specifically it is a breakdown product of dihydrouracil and is produced by the enzyme dihydropyrimidase. It is further decomposed to beta-alanine via the enzyme beta-ureidopropionase. Ureidopropionic acid is essentially a urea derivative of beta-alanine. High levels of Ureidopropionic acid are found in individuals with beta-ureidopropionase (UP) deficiency [PMID: 11675655 ]. Enzyme deficiencies in pyrimidine metabolism are associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 3-(Carbamoylamino)propanoate
- 3-(Carbamoylamino)propanoic acid
- 3-Ureido-propionate
- 3-Ureidopropanoate
- 3-Ureidopropanoic acid
- 3-Ureidopropionate
- 3-Ureidopropionic acid
- beta-Ureidopropionate
- beta-Ureidopropionic acid
- Carbamoyl-b-Ala-OH
- Carbamoyl-beta-Ala-OH
- N-(Aminocarbonyl)-'b-Alanine
- N-(Aminocarbonyl)-b-alanine
- N-(Aminocarbonyl)-beta-Alanine
- N-Carbamoyl-b-alanine
- N-Carbamoyl-beta-alanine
- N-Carbamyl-b-alanine
- N-Carbamyl-beta-alanine
- Ureidopropionate
- Ureidopropionic acid
|
| Chemical Formula |
C4H8N2O3 |
| Average Molecular Weight |
132.1179 |
| Monoisotopic Molecular Weight |
132.053492132 |
| IUPAC Name |
3-(carbamoylamino)propanoic acid |
| Traditional IUPAC Name |
3-ureidopropionic acid |
| CAS Registry Number |
462-88-4 |
| SMILES |
NC(=O)NCCC(O)=O |
| InChI Identifier |
InChI=1S/C4H8N2O3/c5-4(9)6-2-1-3(7)8/h1-2H2,(H,7,8)(H3,5,6,9) |
| InChI Key |
JSJWCHRYRHKBBW-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aliphatic Acyclic Compounds |
| Class |
Alkylamines |
| Sub Class |
1,3-Aminoalcohols |
| Other Descriptors |
- beta-alanine derivative(ChEBI)
|
| Substituents |
|
| Direct Parent |
1,3-Aminoalcohols |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Pantothenate and CoA biosynthesis
- Component of Pyrimidine metabolism
- Component of beta-Alanine metabolism
|
| Application |
Not Available |
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
170 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
20.9 mg/mL |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
Not Available
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Normal |
Inferred from detection in urine
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.0 - 0.5 uM |
Children (1-13 year old) |
Not Specified |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.23 (1.48 - 2.81) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.09 (1.23–4.80) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.88 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.5 (0.0-1.0) uM |
Children (1-13 year old) |
Both |
Dihydropyrimidinase deficiency |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Dihydropyrimidinase deficiency |
- van Kuilenburg AB, Meijer J, Dobritzsch D, Meinsma R, Duran M, Lohkamp B, Zoetekouw L, Abeling NG, van Tinteren HL, Bosch AM: Clinical, biochemical and genetic findings in two siblings with a dihydropyrimidinase deficiency. Mol Genet Metab. 2007 Jun;91(2):157-64. Epub 2007 Mar 26.
Pubmed: 17383919
|
|
| Associated OMIM IDs |
- 222748
(Dihydropyrimidinase deficiency)
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021879 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
109  |
| KEGG Compound ID |
C02642  |
| BioCyc ID |
3-UREIDO-PROPIONATE  |
| BiGG ID |
40270  |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB00026  |
| Metagene Link |
HMDB00026  |
| METLIN ID |
5097  |
| PubChem Compound |
111  |
| PDB ID |
URP  |
| ChEBI ID |
18261  |
| References |
| Synthesis Reference |
w-Ureido carboxylic acids. (1962), 3 pp. GB 913713 19621228 CAN 58:72975 AN 1963:72975 |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Moolenaar SH, Gohlich-Ratmann G, Engelke UF, Spraul M, Humpfer E, Dvortsak P, Voit T, Hoffmann GF, Brautigam C, van Kuilenburg AB, van Gennip A, Vreken P, Wevers RA: beta-Ureidopropionase deficiency: a novel inborn error of metabolism discovered using NMR spectroscopy on urine. Magn Reson Med. 2001 Nov;46(5):1014-7.
Pubmed: 11675655
- Sparidans RW, Bosch TM, Jorger M, Schellens JH, Beijnen JH: Liquid chromatography-tandem mass spectrometric assay for the analysis of uracil, 5,6-dihydrouracil and beta-ureidopropionic acid in urine for the measurement of the activities of the pyrimidine catabolic enzymes. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jul 24;839(1-2):45-53. Epub 2006 Feb 28.
Pubmed: 16513432
- Ito S, Kawamura T, Inada M, Inoue Y, Hirao Y, Koga T, Kunizaki J, Shimizu T, Sato H: Physiologically based pharmacokinetic modelling of the three-step metabolism of pyrimidine using C-uracil as an in vivo probe. Br J Clin Pharmacol. 2005 Dec;60(6):584-93.
Pubmed: 16305582
- Hofmann U, Schwab M, Seefried S, Marx C, Zanger UM, Eichelbaum M, Murdter TE: Sensitive method for the quantification of urinary pyrimidine metabolites in healthy adults by gas chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):371-80.
Pubmed: 12798197
- Malet-Martino MC, Armand JP, Lopez A, Bernadou J, Beteille JP, Bon M, Martino R: Evidence for the importance of 5'-deoxy-5-fluorouridine catabolism in humans from 19F nuclear magnetic resonance spectrometry. Cancer Res. 1986 Apr;46(4 Pt 2):2105-12.
Pubmed: 2936452
- Desmoulin F, Gilard V, Malet-Martino M, Martino R: Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in animal models and human urine. Drug Metab Dispos. 2002 Nov;30(11):1221-9.
Pubmed: 12386128
|